Correction: Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: A role for the angiotensin II receptor AT1 [Breast Cancer Res., 8, (3), (2006) (R33)] DOI: 10.1186/bcr1509;Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: A role for the angiotensin II receptor AT1

Breast Cancer Research

Volumn 8, Issue 3, 2006, Pages

  Lim, Kheng Tian ^a   Cosgrave, Niamh ^a,b   Hill, Arnold David ^a,b   Young, Leonie S ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOTENSIN 2 RECEPTOR; CYCLIC AMP; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; RAF PROTEIN; SARALASIN; SMALL INTERFERING RNA; TYROSINE KINASE RECEPTOR; ANGIOTENSIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BREAST TUMOR; FEMALE; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL CULTURE;

BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC AMP; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHORYLATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 33745637262     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-018-0987-x     Document Type: Erratum

References (33)

1. Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL: A new, nongenomics estrogen action: the rapid release of intracellular calcium. Endocrinology 1992, 131:1305-1312.
2. 2+ influx in LNCaP human prostate cancer cells. Eur J Endocrinol 1996, 135:367-373.
3. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP: Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 1999, 96:4686-4691.
4. Nakhla AM, Khan MS, Rosner W: Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′, 5′-monophosphate. J Clin Endocrinol Metab 1990, 71:398-404.
5. Aronica SM, Kraus WL, Katzenellenbogan BS: Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 1994, 91:8517-8521.
6. Le Mallay V, Grosse B, Lieberherr M: Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem 1997, 272:11902-11907.
7. Migliaccio A, Di Domenico M, Castoria G, de Falco P, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/MAP kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996, 15:1292-1300.
8. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, Kato S, Kawashima H: Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 1997, 235:99-102.
9. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa EM: Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen-activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 1997, 138:4030-4033.
10. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW: Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signalling module in caveolae. Circ Res 2000, 87:E44-E52.
11. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR: Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-AKT pathway in human endothelial cells. Circ Res 2000, 87:677-682.
12. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BS, McLemore MS, Olivo SE, Stoica A: A role for AKT in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 2000, 141:4503-4511.
13. Levin ER: Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 1999, 10:374-377.
14. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I: Non-genomic stimulation of nitric oxide release by estrogen is mediated by ER-alpha localised in caveolae. Biochem Biophys Res Commun 1999, 263:257-263.
15. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER: Estrogen receptors associated with and regulate the production of caveolin: Implications for signalling and cellular actions. Mol Endocrinol 2002, 16:100-115.
16. Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER-alpha and ER-beta expressed in Chinese hamster ovary cells. Mol Endocrinol 1999, 13:307-319.
17. Levin ER: Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005, 19:1951-1959.
18. Evinger AJ, Levin ER: Requirements for ER-alpha membrane localisation and function. Steroids 2005, 70:361-368.
19. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER: Plasma membrane estrogen receptors exist and function as dimmers. Mol Endocrinol 2004, 18:2854-2865.
20. Chambliss KL, Simon L, Yuhanna IS, Mineo C, Shaul PW: Dissecting the basis of nongenomic activation of eNOS by estradiol: Role of ER-alpha domains with known nuclear functions. Mol Endocrinol 2005, 19:277-289.
21. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr: Estrogen induced activation of Erk-1 and Erk-2 requires the G-protein-coupled receptor homolog, GPR30, and occurs via transactivation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
22. Maggiolini M, Vivaeaqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Mantanaro D, Musti AM, Picard D, Ando S: The G protein-coupled receptor GPR30 mediates c-Fos up-regulation by both 17-beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004, 279:27008-27016.
23. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI: Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signalling axis. Mol Endocrinol 2002, 16:70-84.
24. Inwang ER, Puddefoot JR, Brown CL, Goode AW, Marsigliante S, Ho MM, Payne JG, Vinson GP: Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer 1997, 75:1279-1283.
25. Schieffer B, Paxton WG, Marrero MB, Bernstein KE: Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signalling. Hypertension 1996, 27:476-480.
26. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995, 375:247-250.
27. Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C, Marsigliante S: Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol 2003, 196:370-377.
28. Myers E, Fleming JF, Crotty TB, Kelly G, McDermott EW, O'Higgins NJ, Hill AD, Young LS: Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine resistant breast cancer. Br J Cancer 2004, 91:1687-1693.
29. Razandi M, Pedram A, Park ST, Levin ER: Proximal events in signalling by plasma membrane estrogen receptors. J Biol Chem 2003, 278:2701-2712.
30. Filardo EJ: Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signalling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 2002, 80:231-238.
31. Piiper A, Gebhardt R, Kronenberger D, Giannini C, Elez R, Zeuzem S: Pertussis toxin inhibits cholecystokinin-and epidermal growth factor induced mitogen activated protein kinase activation by disinhibition of the cAMP signalling pathway and inhibition of c-Raf-1. Mol Pharmacol 2000, 58:608-613.
32. Melien O, Sandnes D, Johansen J, Christoffersen T: Effects of pertussis toxin on extracellular signal regulated kinase activation in hepatocytes by hormones and receptor-independent agents: evidencesuggesting a stimulatory role of Gi proteins at a level distal to receptor coupling. J Cell Physiol 2000, 184:27-36.
33. 2+ influx. Endocrinology 1999, 140:1385-1391.